TNFRSF10A expression was associated with reduced risk of AMD (OR = 0.84, 95%CI: 0.74–0.95, p = 8.72E-03) and Wet AMD (OR = 0.79, 95%CI: 0.67–0.93, p = 5.73E-03), while CD226 expression was associated with decreased risk of Wet AMD (OR = 0.79, 95%CI: 0.71–0.89, p = 9.36E-05). Here, CD226 is linked to age-related macular degeneration.